CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale EVP & General Counsel sold 1,054 shares at $20.33 ($21,428)
- 4 Open-market sale President sold 4,230 shares at $20.33 ($85,996)
- 4 Open-market sale CEO sold 7,850 shares at $20.33 ($159,591)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP and CFO sold 2,051 shares at $50.61 ($103,801)
- 4 Open-market sale CEO sold 14,195 shares at $50.61 ($718,409)
- 4 Open-market sale President sold 8,429 shares at $50.61 ($426,592)
- 4 Open-market sale EVP & General Counsel sold 2,107 shares at $50.61 ($106,635)
- 4 Open-market sale President sold 700 shares at $55.01 ($38,507)
- 4 Open-market sale EVP and CCO sold 1,120 shares at $53.34 ($59,741)
- 4 Open-market sale EVP & General Counsel sold 678 shares at $53.34 ($36,165)
- 4 Open-market sale EVP and CFO sold 1,016 shares at $53.34 ($54,193)
- 4 Open-market sale President sold 93,077 shares at an average $55.12 ($5,130,031)
- 4 Open-market sale CEO sold 3,484 shares at $53.34 ($185,837)
- 4 Open-market sale President sold 2,728 shares at $53.50 ($145,948)
- 4 Open-market sale EVP & General Counsel sold 8,750 shares at $45.10 ($394,636)
Page 11 of 35 · 686 filings